Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo

Debasish Banerjee, B. Hegedűs, David H. Gutmann, Joel R. Garbow

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1flox/mutGFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1flox/mutGFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.

Original languageEnglish
Pages (from-to)1434-1437
Number of pages4
JournalNeuroImage
Volume35
Issue number4
DOIs
Publication statusPublished - May 1 2007

Fingerprint

Optic Nerve Glioma
Neurofibromatosis 1
Manganese
Magnetic Resonance Imaging
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo. / Banerjee, Debasish; Hegedűs, B.; Gutmann, David H.; Garbow, Joel R.

In: NeuroImage, Vol. 35, No. 4, 01.05.2007, p. 1434-1437.

Research output: Contribution to journalArticle

Banerjee, Debasish ; Hegedűs, B. ; Gutmann, David H. ; Garbow, Joel R. / Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo. In: NeuroImage. 2007 ; Vol. 35, No. 4. pp. 1434-1437.
@article{b7c285c0ce2d4cedb00c54473fef13ca,
title = "Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo",
abstract = "One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1flox/mutGFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1flox/mutGFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.",
author = "Debasish Banerjee and B. Hegedűs and Gutmann, {David H.} and Garbow, {Joel R.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.neuroimage.2007.02.019",
language = "English",
volume = "35",
pages = "1434--1437",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo

AU - Banerjee, Debasish

AU - Hegedűs, B.

AU - Gutmann, David H.

AU - Garbow, Joel R.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1flox/mutGFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1flox/mutGFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.

AB - One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1flox/mutGFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1flox/mutGFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.

UR - http://www.scopus.com/inward/record.url?scp=34147113875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147113875&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2007.02.019

DO - 10.1016/j.neuroimage.2007.02.019

M3 - Article

VL - 35

SP - 1434

EP - 1437

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 4

ER -